Position in CRSP
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,060,975
+$987,064 QoQ
Shares Held
111,129
+4.2% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#61
of 505 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Derivatives in CRSP
reported options exposure · as of Sep 30, 2025CallValue
$1,875
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $44,247,243 across 48 Biotechnology names. CRSP ranks #2 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,557 | $11,571,031 | |
| 2 | CRSP |
CRISPR Therapeutics AG
This page
|
111,129 | $6,060,975 | |
| 3 | CRMD |
CorMedix Inc.
|
415,406 | $3,260,937 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
30,352 | $2,473,991 | |
| 5 | TLX |
Telix Pharmaceuticals Ltd
|
197,250 | $2,274,292 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,130 | $2,051,494 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
165,954 | $1,452,927 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
|
504,000 | $1,305,360 |
All Filings in CRSP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,060,975 | 111,129 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,073,911 | 106,662 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,624,661 | 107,259 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,875 | 300 | Call | Sole | 2025-11-13 | |
| 2025-09-30 | $7,654,903 | 118,113 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,445,199 | 111,949 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,689,464 | 108,418 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,347,016 | 85,036 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,370,674 | 71,747 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $4,192,634 | 77,627 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $923,636 | 13,551 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $558,767 | 8,926 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $256,635 | 5,654 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $282,721 | 5,036 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $225,109 | 4,977 | Shares | Sole | 2023-05-10 | |
| 2022-09-30 | $407,457 | 6,235 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $369,724 | 6,084 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $404,364 | 6,442 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $868,211 | 11,457 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,448,598 | 12,942 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,596,073 | 9,859 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,267,727 | 10,404 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $1,199,157 | 7,832 | Shares | Sole | 2021-04-01 | |
| 2020-09-30 | $375,209 | 4,486 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $382,662 | 5,207 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $206,409 | 4,867 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||